Kestra Medical Technologies：2025年季度报告

(Mark One)☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 For the quarterly period endedJuly 31,2025OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 Kestra Medical Technologies, Ltd. (Exact Name of Registrant as Specified in its Charter) BermudaNot Applicable(State or other jurisdiction ofincorporation or organization)(I.R.S. EmployerIdentification No.)3933 Lake Washington Blvd NE,Suite 200Kirkland,WA98033(Address of principal executive offices)(Zip Code)Registrant’s telephone number, including area code: (425)279-8002 Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) hasbeen subject to such filing requirements for the past 90 days.Yes☐No☒ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant toRule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was requiredto submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and“emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer☐Non-accelerated filer☒ Accelerated filer☐Smaller reporting company☒Emerging growth company☒ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☒As of September 11, 2025, the registrant had51,449,053Common Shares, par value $1.00 per share, outstanding. Table of Contents PART I.FINANCIAL INFORMATION Item 1.Condensed Consolidated Balance Sheets4Condensed Consolidated Statements of Operations and Comprehensive Loss5Condensed Consolidated Statements of Changes in Redeemable Preferred Stock and Shareholders’ Equity(Deficit)6Condensed Consolidated Statements of Cash Flows7Notes to Condensed Consolidated Financial Statements8Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations19Item 3.Quantitative and Qualitative Disclosures About Market Risk28Item 4.Controls and Procedures28 PART II.OTHER INFORMATION Item 1.Legal ProceedingsItem 1A.Risk FactorsItem 2.Unregistered Sales of Equity Securities and Use of ProceedsItem 3.Defaults Upon Senior SecuritiesItem 4.Mine Safety DisclosuresItem 5.Other InformationItem 6.ExhibitsSignatures 3131313131313233 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q (the “Quarterly Report”) contains “forward-looking” statements within the meaningof the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are basedon our management’s beliefs and assumptions and on information currently available to our management. The forward-lookingstatements are contained principally in the section captioned “Management’s Discussion and Analysis of Financial Condition andResults of Operations.” Forward-looking statements include information concerning our possible or assumed future results of operations, businessstrategies, technology developments, financing and investment plans, dividend policy, competitive position, industry and regulatoryenvironment, potential growth opportunities and the effects of competition. Forward looking statements include statements that arenot historical facts and can be identified by terms such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,”“intend,” “may,” “might,” “objective,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will” and “would,” or thenegative of these terms, or other comparable terminology intended to identify statements about the future. Forward-lookingstatements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance orachievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Important factors that could cause actual results, performance or achievements to differ materially from our expectationsare described in Part II, Item 1A, “Risk Factors” and elsewhere in this Quarterly Report, and include, but are not limited to, thefollowing: •our ability to continue to expand the commercialization of our ASSURE WCD, including associated products andservices as part of our Cardiac Recovery System platform, or to commercialize any future product candidates andbegin generating revenue; •our abil